These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 15908014)
21. A broadly applicable, personalized heat shock protein-mediated oncolytic tumor vaccine. Huang XF; Ren W; Rollins L; Pittman P; Shah M; Shen L; Gu Q; Strube R; Hu F; Chen SY Cancer Res; 2003 Nov; 63(21):7321-9. PubMed ID: 14612530 [TBL] [Abstract][Full Text] [Related]
22. [New strategy of cancer immunotherapy: irradiation or chemotherapeutics-induced lymphopenia combined with immune reconstitution and tumor vaccine]. Ma J; Wang YL; Hu HM; Fox BA; Si LS Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):452-6. PubMed ID: 16188138 [TBL] [Abstract][Full Text] [Related]
23. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
24. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope. Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501 [TBL] [Abstract][Full Text] [Related]
25. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity]. You J; Wang CL; Hao XS Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273 [TBL] [Abstract][Full Text] [Related]
26. Effective treatment of preexisting melanoma with whole cell vaccines expressing alpha(1,3)-galactosyl epitopes. Rossi GR; Mautino MR; Unfer RC; Seregina TM; Vahanian N; Link CJ Cancer Res; 2005 Nov; 65(22):10555-61. PubMed ID: 16288048 [TBL] [Abstract][Full Text] [Related]
27. Sustained cytokine delivery for anticancer vaccination: liposomes as alternative for gene-transfected tumor cells. Koppenhagen FJ; Küpcü Z; Wallner G; Crommelin DJ; Wagner E; Storm G; Kircheis R Clin Cancer Res; 1998 Aug; 4(8):1881-6. PubMed ID: 9717815 [TBL] [Abstract][Full Text] [Related]
28. [Anti-tumor immune responses of nanoemulsion-encapsulated MHS vaccine]. Ge W; Sun YJ; Li Y; Zhang SH; Zhang XM; Huang Y; Hu PZ; Sui YF Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):457-60. PubMed ID: 18466701 [TBL] [Abstract][Full Text] [Related]
29. Scavenger receptor-A negatively regulates antitumor immunity. Wang XY; Facciponte J; Chen X; Subjeck JR; Repasky EA Cancer Res; 2007 May; 67(10):4996-5002. PubMed ID: 17510431 [TBL] [Abstract][Full Text] [Related]
30. Fusion protein of ATPase domain of Hsc70 with TRP2 acting as a tumor vaccine against B16 melanoma. Zhang H; Wang W; Li Q; Huang W Immunol Lett; 2006 Jun; 105(2):167-73. PubMed ID: 16580737 [TBL] [Abstract][Full Text] [Related]
31. A novel chimeric DNA vaccine: enhancement of preventive and therapeutic efficacy of DNA vaccine by fusion of Mucin 1 to a heat shock protein 70 gene. Choi DH; Woo JK; Choi Y; Seo HS; Kim CW Mol Med Rep; 2011; 4(5):885-90. PubMed ID: 21725596 [TBL] [Abstract][Full Text] [Related]
32. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control. Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230 [TBL] [Abstract][Full Text] [Related]
33. Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. Nair S; Boczkowski D; Fassnacht M; Pisetsky D; Gilboa E Cancer Res; 2007 Jan; 67(1):371-80. PubMed ID: 17210720 [TBL] [Abstract][Full Text] [Related]
34. [Mechanism of augmented anti-tumor immunity in reconstituted lymphopenic mice immunized with melanoma vaccine]. Ma J; Wang YL; Hu HM; Fox BA; Si LS Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):708-12. PubMed ID: 16483476 [TBL] [Abstract][Full Text] [Related]
35. GM-CSF-surface-modified B16.F10 melanoma cell vaccine. Gao J; Huang S; Li M; Luo R; Wang X; Takashima A Vaccine; 2006 Jun; 24(25):5265-8. PubMed ID: 16713660 [TBL] [Abstract][Full Text] [Related]
36. Heat shock fusion protein induces both specific and nonspecific anti-tumor immunity. Li D; Li H; Zhang P; Wu X; Wei H; Wang L; Wan M; Deng P; Zhang Y; Wang J; Liu Y; Yu Y; Wang L Eur J Immunol; 2006 May; 36(5):1324-36. PubMed ID: 16619287 [TBL] [Abstract][Full Text] [Related]
37. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies. Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962 [TBL] [Abstract][Full Text] [Related]
38. A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses. Conforti A; Peruzzi D; Giannetti P; Biondo A; Ciliberto G; La Monica N; Aurisicchio L J Immunother; 2009 Sep; 32(7):744-54. PubMed ID: 19561534 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of anti-tumor effects of tumor cell lysate enriched by HSP-70 against fibrosarcoma tumor in BALB/c mice. Hashemi SM; Hassan ZM; Soudi S; Ghazanfari T; Kheirandish M; Shahabi S Int Immunopharmacol; 2007 Jul; 7(7):920-7. PubMed ID: 17499194 [TBL] [Abstract][Full Text] [Related]
40. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice. Ling X; Wang Y; Dietrich MF; Andreeff M; Arlinghaus RB Oncogene; 2006 Jul; 25(32):4483-90. PubMed ID: 16547503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]